BioSpace News Archive

Sonoma Pharmaceuticals, Inc. today announced financial results for its second fiscal quarter and six months ended September 30, 2021.

Asher Biotherapeutics today announced that company management will participate in the following upcoming investor conferences: Piper Sandler 33rd Annual Virtual Healthcare Conference

Alchemab Therapeutics today announced the appointment of Young T. Kwon, PhD as Chief Financial and Operating Officer.

NiKang Therapeutics Inc. today announced that the first patient has been dosed in a phase 1/2, open-label, dose escalation and expansion study of single agent NKT2152, a small molecule that inhibits hypoxia inducible factor 2α (HIF2α).

Savara Inc. today announced that its management team will present at the following healthcare conferences: Piper Sandler 33rd Annual Virtual Healthcare Conference

NTT Research, Inc., a division of NTT, announced that scientists affiliated with its Medical & Health Informatics Lab and the Technical University of Munich have written a paper on the design and capabilities of 3D-printable, transformable materials that inflict reduced damage on target tissue and exhibit enhanced functionality.

Ocular Therapeutix, Inc. today announced that it will participate at the following conferences: Jefferies London Healthcare Conference

Shanghai Junshi Biosciences Co. and Coherus Biosciences, Inc. announced today that the United States Food and Drug Administration (“FDA”) has granted Orphan Drug Designation (ODD) for toripalimab for the treatment of esophageal cancer.

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company committed to being the leader in responsible pain management, announced that it has entered into an Accelerated Share Repurchase agreement with Jefferies LLC to repurchase $25 million of the Company’s common stock.

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today reports its financial results and provides an update on its operational progress for the third quarter and nine months ended September 30, 2021.